HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Howard A Burris Selected Research

BMS 310705

4/2008Preclinical investigations with epothilones in breast cancer models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Howard A Burris Research Topics

Disease

113Neoplasms (Cancer)
11/2022 - 01/2002
63Breast Neoplasms (Breast Cancer)
10/2022 - 01/2002
26Neutropenia
01/2021 - 05/2003
22Diarrhea
01/2019 - 05/2003
21Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 05/2005
18Fatigue
01/2020 - 12/2007
16Disease Progression
01/2020 - 04/2003
16Thrombocytopenia (Thrombopenia)
10/2019 - 02/2002
14Carcinoma (Carcinomatosis)
12/2021 - 03/2002
13Nausea
01/2020 - 11/2005
13Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2018 - 05/2002
11Vomiting
01/2020 - 11/2005
11Exanthema (Rash)
01/2019 - 08/2005
9Neoplasm Metastasis (Metastasis)
03/2016 - 04/2008
8Febrile Neutropenia
01/2018 - 02/2002
8Anemia
01/2018 - 06/2010
8Colorectal Neoplasms (Colorectal Cancer)
05/2015 - 08/2007
5Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 05/2010
5Mucositis
10/2017 - 05/2009
5Melanoma (Melanoma, Malignant)
03/2016 - 09/2010
4Renal Cell Carcinoma (Grawitz Tumor)
11/2020 - 12/2007
4Pain (Aches)
08/2018 - 03/2010
4Infections
01/2018 - 10/2011
4Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018 - 10/2002
4Prostatic Neoplasms (Prostate Cancer)
08/2017 - 03/2007
4Stomatitis
02/2017 - 02/2012
4Fever (Fevers)
01/2017 - 10/2008
4Pancreatic Neoplasms (Pancreatic Cancer)
04/2013 - 03/2005
3Hyperglycemia
01/2019 - 02/2012
3Alopecia (Baldness)
01/2018 - 07/2015
3Pneumonia (Pneumonitis)
01/2018 - 02/2012
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 07/2002

Drug/Important Bio-Agent (IBA)

26Carboplatin (JM8)FDA LinkGeneric
12/2019 - 03/2002
22Paclitaxel (Taxol)FDA LinkGeneric
08/2017 - 01/2002
20Hormones (Hormone)IBA
10/2022 - 03/2010
20Trastuzumab (Herceptin)FDA Link
11/2019 - 01/2004
17EverolimusFDA Link
01/2020 - 04/2008
17Bevacizumab (Avastin)FDA Link
09/2019 - 12/2007
16Pharmaceutical PreparationsIBA
01/2020 - 05/2002
16GemcitabineFDA Link
04/2013 - 03/2002
14Ado-Trastuzumab EmtansineIBA
11/2019 - 06/2010
14Docetaxel (Taxotere)FDA Link
01/2017 - 05/2005
11ErbB Receptors (EGF Receptor)IBA
11/2019 - 08/2005
11Irinotecan (Camptosar)FDA LinkGeneric
01/2015 - 05/2003
10exemestane (Aromasin)FDA Link
01/2021 - 02/2012
10taxaneIBA
11/2019 - 01/2002
9Aromatase InhibitorsIBA
01/2021 - 02/2012
9Immunoconjugates (Immunoconjugate)IBA
01/2020 - 06/2010
9Pemetrexed (MTA)FDA Link
12/2019 - 01/2010
8PlatinumIBA
01/2020 - 02/2002
8Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018 - 12/2007
7Biomarkers (Surrogate Marker)IBA
11/2022 - 08/2013
7human ERBB2 proteinIBA
10/2022 - 02/2011
7Doxorubicin (Adriamycin)FDA LinkGeneric
08/2017 - 06/2008
7ixabepilone (BMS 247550)FDA Link
08/2017 - 03/2007
7Monoclonal AntibodiesIBA
04/2013 - 03/2010
6Biological ProductsIBA
01/2020 - 03/2002
6pertuzumabIBA
11/2019 - 09/2012
6pegfilgrastim (Neulasta)FDA Link
01/2018 - 06/2008
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2017 - 06/2008
6Angiogenesis InhibitorsIBA
05/2015 - 01/2010
6Capecitabine (Xeloda)FDA Link
02/2014 - 01/2010
6Lapatinib (GW572016)FDA Link
06/2011 - 01/2004
6Topotecan (Hycamtin)FDA LinkGeneric
05/2011 - 05/2002
5Letrozole (Femara)FDA LinkGeneric
10/2022 - 11/2016
5ribociclibIBA
10/2022 - 11/2016
5Estrogen ReceptorsIBA
01/2020 - 05/2013
5pazopanibFDA Link
01/2018 - 01/2010
5TOR Serine-Threonine KinasesIBA
01/2016 - 04/2008
5Epidermal Growth Factor (EGF)IBA
08/2013 - 05/2010
5Epothilones (Epothilone)IBA
10/2012 - 03/2007
4atezolizumabIBA
01/2022 - 11/2014
4Fulvestrant (Faslodex)FDA Link
01/2021 - 06/2011
4Sorafenib (BAY 43-9006)FDA Link
11/2017 - 05/2010
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2017 - 05/2011
4dabrafenibIBA
03/2016 - 11/2012
4trametinibIBA
03/2016 - 08/2012
4AnthracyclinesIBA
12/2014 - 04/2009
4Fluorouracil (Carac)FDA LinkGeneric
07/2012 - 01/2002
4Cetuximab (Erbitux)FDA Link
07/2010 - 08/2007
4Vinorelbine (Navelbine)FDA LinkGeneric
08/2009 - 04/2003
3Immune Checkpoint InhibitorsIBA
11/2022 - 05/2016
3AndrogensIBA
01/2022 - 03/2007
3Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021 - 08/2017
3rucaparibIBA
12/2021 - 08/2017
3Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2021 - 11/2016
3Anastrozole (Arimidex)FDA LinkGeneric
01/2021 - 06/2011
3Mechanistic Target of Rapamycin Complex 1IBA
11/2020 - 04/2013
3Messenger RNA (mRNA)IBA
12/2019 - 04/2013
3Tumor Biomarkers (Tumor Markers)IBA
11/2019 - 01/2019
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2019 - 10/2017
3AZD 6244IBA
10/2017 - 01/2017

Therapy/Procedure

59Therapeutics
10/2022 - 07/2002
27Drug Therapy (Chemotherapy)
01/2021 - 07/2002
7Radiotherapy
01/2016 - 07/2002
6Neoadjuvant Therapy
11/2015 - 06/2008
4Combination Drug Therapy (Combination Chemotherapy)
01/2018 - 03/2002
4Aftercare (After-Treatment)
01/2016 - 05/2010
3Immunotherapy
01/2022 - 09/2010
3Intravenous Infusions
01/2020 - 11/2010